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Abstract
Background: Human β-defensin (hBD)-2, antimicrobial peptide primarily induced in epithelial
cells, is a key factor in the innate immune response of the respiratory tract. Several studies showed
increased defensin levels in both inflammatory lung diseases, such as cystic fibrosis, diffuse
panbronchiolitis, idiopathic pulmonary fibrosis and acute respiratory distress syndrome, and
infectious diseases. Recently, epidemiologic studies have demonstrated acute and serious adverse
effects of particulate air pollution on respiratory health, especially in people with pre-existing
inflammatory lung disease. To elucidate the effect of diesel exhaust particles (DEP) on pulmonary
innate immune response, we investigated the hBD-2 and interleukin-8 (IL-8) expression to DEP
exposure in interleukin-1 beta (IL-1β)-stimulated A549 cells.
Results: IL-1β markedly up-regulated the hBD-2 promoter activity, and the subsequent DEP
exposure increased dose-dependently the expression of hBD-2 and inflammatory cytokine IL-8 at
the transcriptional level. In addition, DEP further induced the NF-κB activation in IL-1β-stimulated
A549 cells more rapidly than in unstimulated control cells, which was showed by nuclear
translocation of p65 NF-κB and degradation of IκB-α. The experiment using two NF-κB inhibitors,
PDTC and MG132, confirmed that this increase of hBD-2 expression following DEP exposure was
regulated through NF-κB-mediated pathway.
Conclusion:  These results demonstrated that DEP exposure increases the expression of
antimicrobial peptide and inflammatory cytokine at the transcriptional level in IL-1β-primed A549
epithelial cells and suggested that the increase is mediated at least partially through NF-κB
activation. Therefore, DEP exposure may contribute to enhance the airway-responsiveness
especially on the patients suffering from chronic respiratory disease.
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Background
Diesel exhaust particles (DEP), which are generated by
heavy-duty diesel engines, are major constituents of the
atmospheric respiratory particles of less than 2.5 μm
(PM2.5) in industrialized urban areas. With diameters <
2.5 μm, these particles can remain airborne for long peri-
ods of time and get deposited in great numbers deeply in
the lungs. To date, many studies have demonstrated that
DEP exposure is linked to the incidence of pulmonary
inflammation and allergic airway disease, particularly
asthma, [1-4] and increased susceptibility to bacterial
infection [5-7].
Some interesting epidemiologic data have shown that the
health effects of DEP are easily observed in people with
pre-existing inflammatory lung diseases such as bronchi-
tis, asthma, chronic obstructive pulmonary disease, pneu-
monia and compromised immune system, and age over
65 year old [8,9]. Recently studies have been reported that
DEP may cause a change in innate and T cell-mediated
immune responses [7] and be a potent adjuvant for the
development of Th2 response characteristic of allergy and
asthma in animal experiments [10,11]. Another study
showed that lung macrophages activated by LPS might
promote further inflammation by an enhanced cytokine
response to inhaled air particles [12,13]. This evidence
indicates that DEP exposure influences lung susceptibility
in the inflammatory milieu of environment lung diseases.
Host defense against infection involves a multitude of fac-
tors and cells that together form the elements of innate
and acquired immunity [14,15]. Especially, innate
immune system, the first line of host defense, consists of
a range of pre-existing, rapidly mobilized host defenses.
Pulmonary epithelial cells that are a primary interface in
direct contact with the ambient environment are a crucial
site for this innate immune response. These cells generate
various immune effectors such as cytokines, chemokines
and antimicrobial peptides in response to inflammatory
stimuli, and regulate the activation and recruitment of
phagocytes, including neutrophils and macrophages, and
immune cells with T cells and dendritic cells.
Antimicrobial peptides are key effector molecules in the
innate immune system of the lung by virtue of their
broad-spectrum microbicidal activity. Based on their
structural characteristics, human defensins are divided
into two subfamilies: α-defensin and β-defensin. Human
α-defensins are mainly stored in the granules of phago-
cytes and Paneth cells, whereas human β-defensins
(hBDs) are largely expressed in various epithelial tissues,
including lung and skin [15-17]. The first hBD (hBD-1)
was isolated in 1995 from hemofiltrate, and was later
shown to be present in epithelial cells in various organs,
entirely in a constitutive manner. The second hBD (hBD-
2), initially found in psoriatic skin, is detected in airway
surface fluid from patients with infectious lung disease
but not from normal volunteers [18-20]. The mRNA for
hBD-2 is present in the human lung and up-regulated by
chronic inflammation, bacterial LPS or a proinflamma-
tory mediator IL-1β. Other studies [21,22] demonstrated
that the expression of hBD-2 in epithelial cells is ampli-
fied by LPS-stimulated monocytic cells through the pro-
duction of IL-1β and TNF-α.
Most studies on defensins have mainly focused on their
direct antimicrobial activity. However, a wide variety of
recent in vitro and in vivo studies have illustrated the capac-
ity of defensins to modulate the immunological and
inflammatory responses [20,23], suggesting that their
activities in the innate immune system may be closely
linked to the inflammatory process.
Considering the roles of defensins in the initial defence
response, it is important to elucidate the molecular mech-
anisms regulating their expression in a condition suscep-
tible to external stimulus. In the present study, we focused
on the effect of DEP on the inducible expression of hBD-
2 and an inflammatory cytokine IL-8 in IL-1β-primed
A549 lung epithelial cells. The results showed that DEP
up-regulated the expression of endogenous hBD-2 and IL-
8 mRNA in A549 cells and that the increase of hBD-2
expression was mediated through activation of NF-κB.
This study provides insights into the pathogenesis of
inflammatory lung disease following DEP exposure.
Results
Activation of hBD-2 promoter in IL-1β-stimulated A549 
epithelial cells
Lung epithelial cells have been reported to participate in
innate host defense by expressing antimicrobial peptide
hBD-2 in response to inflammatory stimuli such as LPS
and proinflammatory cytokines [14,19,22]
We tried to evaluate the ability of A549 alveolar type II
epithelial cells to induce hBD-2 expression following IL-
1β stimulation and/or DEP exposure. As shown in Figure
1, hBD-2 promoter activity was increased dose-depend-
ently after treatment with IL-1β (50–10,000 pg/ml) for 6
h. However, treatment of DEP (1–100 μg/ml) or LPS (up
to 100 μg/ml) did not significantly induce activation of
hBD-2 promoter (data not shown), which was consistent
with the published results in the same cell line [22,24].
These results suggest that A549 epithelial cells may be sen-
sitive to proinflammatory cytokine IL-1β. In a subsequent
experiment, we used IL-1β as an activator to induce hBD-
2 expression.Particle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
Page 3 of 9
(page number not for citation purposes)
DEP increased IL-1β-induced hBD-2 expression in lung 
epithelial cells
To determine the effect of DEP on the IL-1β-induced hBD-
2 expression, we pretreated A549 cells with IL-1β of 50 pg/
ml, sufficient concentration to induce hBD-2 expression
in our experiment and evaluated their response to DEP
exposure. In the presence of IL-1β, DEP linearly increased
the hBD-2 promoter activity over a concentration range of
5 to 100 μg/ml. Nevertheless, in its absence, DEP showed
no change in the hBD-2 promoter activity (Figure 2(A)).
Next, we examined the endogenous level of hBD-2 mRNA
following DEP exposure under the same culture condi-
tion. As shown in Figure 2(B), hBD-2 mRNA level was
markedly increased, reached a peak level at 10 and 100
μg/ml DEP, and rapidly reduced at 200 μg/ml DEP.
Also, the degree of hBD-2 induction was quantitatively
screened by real-time PCR. Consistent with the results of
RT-PCR, DEP concentrations of 10 and 100 μg/ml
increased the expression of hBD-2 mRNA by about 60-
and 50-fold, respectively, in IL-1β-stimulated cells,
whereas they did not at all in cells exposed to DEP alone
(Figure 2(C)). Actually, a DEP dose of 200 μg/ml showed
cell viability decreased to 62 and 85% in experiments
using cytotoxicity assay and LDH release, respectively
(data not shown), which may have contributed to a low
expression level of hBD-2. These results indicate that DEP
exposure increases IL-1β-induced hBD-2 expression at the
transcriptional level in A549 cells.
DEP increased IL-1β-induced IL-8 expression in lung 
epithelial cells
In the innate immune response, epithelial cells generate
various immune effectors such as cytokines, chemokines,
and nitric oxide, as well as antimicrobial peptides. Among
cytokines, IL-8 is a pivotal inflammatory cytokine, which
is involved in allergic inflammatory disorders such as
asthma and has biological activities on eosinophils, the
predominant cells in bronchial asthma, and neutrophils
[25]. In this study, we examined the expression of IL-8 as
an indicator to investigate the cellular inflammatory
responses.
As shown in Figure 3, DEP dose-dependently increased
the expression level of endogenous IL-8 mRNA in IL-1β-
stimulated cells, whereas DEP exposure alone showed
almost no induction (Figure 3(A)). This was consistent
with the results obtained in real-time PCR analysis (Figure
3(B)). However, compared to IL-1β-pretreatment control,
DEP treatment did not induce any increase of IL-8 protein
in culture media (data not shown). A similar discrepancy
between mRNA expression and its protein secretion has
been reported in other studies that detected the level of
cytokines in the supernatant of cultured cells by ELISA
method [23,26,27]. The authors postulated that these dif-
ferences were caused by either the lack of the protease to
cleave the immature form into the mature cytokine in the
in vitro environment, or the intracellular storage or bind-
ing to the cell surface of cytokine. Taken together, these
results indicated that DEP increase the expression of IL-8
at a transcriptional level in IL-1β-stimulated A549 cells,
although the level of protein release was not correlated
with that of mRNA expression.
hBD-2 expression was mediated through NF-κB activation 
in IL-1β-stimulated A549 cells
IL-1β and TNF-α initiate NF-κB signaling and induce the
transcription of several genes involved in innate immune
response [22,27]. Based on these reports, we constructed
the proximal promoter region of the hBD-2 gene contain-
ing three NF-κB binding motifs and addressed the
involvement of NF-κB on hBD-2 regulation in IL-1β-stim-
ulated A549 cells.
In our study, the activation of NF-κB was assessed by the
nuclear translocation of p65 NF-κB and the degradation
of IκB-α, a NF-κB inhibitory protein. Treatment with 50
pg/ml IL-1β in A549 cells resulted in the marked nuclear
translocation of p65 NF-κB and a concomitant degrada-
tion of IκB-α in the cytosol, which peaked at 5 min after
Induction of hBD-2 promoter activity by proinflammatory  cytokine IL-1β in A549 cells Figure 1
Induction of hBD-2 promoter activity by proinflammatory 
cytokine IL-1β in A549 cells. A549 cells were transfected 
with the luciferase plasmid containing hBD-2 promoter for 
20 h and stimulated with the indicated concentrations of IL-1 
β for 6 h. The cells were harvested and assayed for luciferase 
activity as described in Methods. Luciferase activities were 
expressed as a fold-activation relative to the un-stimulated 
control. Values are mean ± SD of five independent experi-
ments. *, P < 0.0001.Particle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
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IL-1β treatment and gradually recovered after 1 h (Figure
4(A)). In addition, subsequent DEP exposure synergically
increased the IL-1β-induced NF-κB activation.
Using two NF-κB inhibitors, PDTC and MG132, we deter-
mined the involvement of NF-κB in IL-1β-induced hBD-2
expression. Pretreatment of NF-κB inhibitors effectively
suppressed the IL-1β-induced nuclear translocation of
p65 NF-κB and IκB-α degradation in A549 cells (Figure
4(B)). Furthermore, the IL-1β-induced hBD-2 mRNA
expression and hBD-2 promoter activity were inhibited by
pretreatment with inhibitors (Figure 4(C, D)). These
results suggest that hBD-2 expression in lung epithelial
cells is in part modulated by NF-κB transcription factor via
the action of IL-1β.
Discussion
Airway epithelial cells are constantly exposed to inhaled
airborne pathogens and produce several effectors to pro-
tect the lung from them. Among these biological effectors,
hBD-2 is an interesting antimicrobial peptide, which is
able to modulate inflammatory responses and stimulate
adaptive immunity in addition to the microbicidal activ-
ity in innate immunity [15,17,28]. In particular, it has
been reported that under hyper-responsive inflammatory
conditions such as asthma or viral infection, epithelial
Effect of DEP on the expression of IL-1β-induced hBD-2 mRNA in A549 cells Figure 2
Effect of DEP on the expression of IL-1β-induced hBD-2 mRNA in A549 cells. (A) A549 cells were transfected with the luci-
ferase plasmid containing hBD-2 promoter for 20 h. After pre-treatment with 50 pg/ml IL-1β for 1 h, the cells were exposed to 
5–200 μg/ml of DEP for 24 h. The cells were harvested and assayed for luciferase activity as described in Methods. Luciferase 
activities are expressed as a fold-activation relative to the IL-1β only-treated control. Values are mean ± SD of five independent 
experiments. *, P < 0.005. Also, A549 cells were stimulated with 50 pg/ml IL-1β for 1 h and then treated with 5–200 μg/ml of 
DEP for 20 h. Total RNA was extracted and RT-PCR (B) and real-time quantification PCR (C) were performed using specific 
primers for hBD-2 and β-tubulin. The hBD-2 signals were normalized to β-tubulin and are presented in arbitrary units (A.U.).Particle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
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cells show a change of immune response to environmen-
tal particles exposure [29-31]. In this study, we examined
the expression of hBD-2 and inflammatory cytokine IL-8
following DEP exposure in IL-1β-stimulated A549 lung
epithelial cells and demonstrated the regulation of hBD-2
expression by NF-κB.
Consistent with previous reports that A549 cells were
hyper-responsive to IL-1β [32,33], pretreatment of A549
cells with IL-1β markedly induced hBD-2 promoter activa-
tion at a low dose (50 pg/ml), while DEP alone showed
no effect. Treatment of DEP in IL-1β-pretreated A549 cells
increased the activity of hBD-2 promoter in a dose-
dependent manner. In addition, we showed that DEP
exposure increased hBD-2 and IL-8 expression at the tran-
scriptional level in the same IL-1β-primed condition using
RT-PCR and quantitative real-time PCR. These findings
suggest that epithelial cells stimulated by IL-1β are sensi-
tive to the exposure of subsequent environmental parti-
cles, DEP, which may result in increased expression of
antimicrobial peptide and inflammatory cytokine at the
transcriptional level.
In the lungs, while pulmonary epithelial cells rarely
respond to bacteria or bacterial LPS, the cells readily
respond to cytokines being triggered at a lower threshold
[16,34,35]. Furthermore, recent studies have shown that
epithelial cells modulate hBD transcription via pro-
inflammatory cytokines (IL-1β and TNF-α) produced by
LPS-stimulated, mononuclear phagocytes [21,22]. Previ-
ous studies [22,24,36] demonstrated that this hypo-
responsiveness of epithelial cells to LPS was most likely
due to lack of expression and membrane localization of
toll-like receptor 4 (TLR4), which is required for recogni-
tion of bacterial component and signal transducer mole-
cule to initiate the LPS signaling. Actually, we could not
observe detectable levels of TLR4 in A549 cells by RT-PCR
and western blotting assay, even after treatment with LPS
(data not shown). Another study [24] suggested that epi-
thelial cells that are in frequent contact with environmen-
tal stimuli (intestine and lung) are hypo-responsive to LPS
at baseline and need a priming event to induce LPS
responsiveness. In our study, we used IL-1β as a pro-
inflammatory factor to induce responsiveness of A549
cells. The cells stimulated with a low dose of IL-1β (50 pg/
ml) increased hBD-2 promoter activity up to 20 fold.
It has been also reported that transcriptional activation of
hBD-2 is regulated in an NF-κB dependent manner
[22,27]. The known genes regulated by NF-κB are pro-
inflammatory cytokines, chemokines, antimicrobial pep-
tides, inducible enzymes and adhesion molecules which
are important effectors or mediators of innate and adap-
tive immune responses. We showed that IL-1β induced
the activation of NF-κB via the degradation of IκB-α and
the translocation of p65, a subunit of NF-κB, into the
nucleus, and that subsequent DEP treatment increased the
NF-κB activation time-dependently. In addition, we
examined the involvement of NF-κB in hBD-2 transcrip-
tion using two NF-κB inhibitors (MG132 and PDTC) with
Effect of DEP on the expression of IL-1β-induced IL-8 mRNA in A549 cells Figure 3
Effect of DEP on the expression of IL-1β-induced IL-8 mRNA in A549 cells. A549 cells were stimulated with 50 pg/ml IL-1β for 
1 h and then treated with 1–200 μg/ml of DEP for 20 h. Total RNA was extracted as described in Methods. The mRNA levels 
of IL-8 and β-tubulin were analyzed by RT-PCR (A) and real-time quantification PCR (B). The IL-8 signals were normalized to 
β-tubulin and are presented in arbitrary units (A.U.).Particle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
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different pharmacological actions. Both inhibitors effec-
tively reduced the hBD-2 expression induced by IL-1β
alone and by the combination of IL-1β and DEP. These
results indicate that hBD-2 is induced via activation of NF-
κB in IL-1β-stimulated A549 cells and that DEP exposure
up-regulates this mechanism of hBD-2 expression.
The previous studies demonstrated multiple regulatory
pathways in β-defensin expression and regulation, which
supports their pluripotential functional abilities. While
initially perceived as being primarily antimicrobial in
nature and contributing to the barrier protection of epi-
thelial and mucosal surfaces, as suggested by the name
'defensin', it is now known that the β-defensin has an
important role in not only the innate immune response,
but also in immunoenhancing, inflammatory modulating
and wound repairing capabilities. In a series of studies,
elevated levels of α- and β-defensin, especially hBD-2,
DEP regulate IL-1β-induced NF-κB activation in A549 cells Figure 4
DEP regulate IL-1β-induced NF-κB activation in A549 cells. (A) A549 cells were stimulated with 50 pg/ml IL-1β for 1 h and 
treated with 100 μg/ml DEP for the indicated times. At each time point, the nuclear and cytosolic fractions were prepared and 
used for the analysis of p65 NF-κB, IκB-α and β-actin levels by Western blotting. (B) A549 cells were pretreated with MG132 
(5 μM) or PDTC (100 μM) for 1 h and then stimulated with IL-1β (50 pg/ml) for 1 h followed by DEP treatment (100 μg/ml) for 
5 min. The levels of p65 NF-κB, IκB-α and β-actin were analyzed by western blotting as mentioned above. (C) A549 cells were 
transfected with luciferase plasmid containing hBD-2 promoter for 20 h. The cells were pretreated with MG132 (5 μM) or 
PDTC (100 μM) for 1 h and then stimulated with IL-1β (50 pg/ml) for 1 h followed by DEP treatment (50 μg/ml) for 24 h. The 
cells were harvested and assayed for luciferase activity as described in Methods. Values are mean ± SD of four independent 
experiments. (D) A549 cells were pretreated with MG132 (5 μM) or PDTC (100 μM) for 1 h and then stimulated with IL-1β 
(50 pg/ml) for 1 h followed by DEP treatment (10 μg/ml) for 20 h. Total RNA was prepared and analyzed by RT-PCR using spe-
cific primers for hBD-2 and β-tubulinParticle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
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were observed in the plasma of bronchoalveolar lavage
fluid (BALF) of patients with various inflammatory lung
diseases [18,37,38]. Furthermore, recent in vitro studies
have showed that the levels of defensin strongly correlate
with those of the increased IL-8 from airway epithelial
cells [23,39,40], which may contribute to some effect
exerted by defensin on IL-8 synthesis and additional
effects on lung chronic inflammation.
This is the first report to demonstrate the relationship
between β-defensin and DEP-induced airway inflamma-
tion. Although our results did not show a direct relation
between hBD-2 and IL-8 expression, we have suggested in
this study that DEP exposure could synergistically induce
increases of hBD-2 and IL-8 with chemotactic functions in
IL-1β-primed lung epithelial cells, which may serve as cru-
cial signal in mediating the initiation, mobilization and
amplification of adaptive immune responses.
Conclusion
This study showed that DEP, which constitute an impor-
tant airborne pollutant in the urban environment, regu-
lates the transcriptional expression of an antimicrobial
peptide (hBD-2) and an inflammatory cytokine (IL-8) in
IL-1β-stimulated A549 cells. From the finding, we have
demonstrated the possibility of immunoenhancing in
response to DEP exposure in lung epithelial cells. This
suggests that the heightened inflammatory response
might provide an insight to explain the adverse effect fol-
lowing particulate air pollution exposure in patients with
pre-existing inflammatory lung disease. Finally, further
investigation of intracellular response to DEP exposure
will contribute to raising the understanding of the pulmo-
nary innate immune system and the adverse health effects
of DEP.
Methods
Reagents
The diesel particulate matter SRM 2975 was purchased
from the National Institute of Standards and Technology
(Gaithersburg, MD), and human recombinant IL-1β from
R & D System (Minneapolis, MN). Antibodies against p65
NF-κB (sc-8008), IκB-α (sc-847), and β-tubulin (sc-5274)
were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA), and the proteasome inhibitors, MG132 and
pyrrolidine dithiocarbamate (PDTC), from Sigma-Aldrich
(St. Louis, MO). MG132 and PDTC were dissolved in
DMSO and further diluted in PBS to ensure a DMSO con-
centration not exceeding 0.1%.
Cell cultures
The human lung alveolar type II epithelial cell line, A549
(CCL-185), was obtained from the American Type Culture
Collection (Manassas, VA). A549 cells were maintained in
RPMI-1640 medium (WelGENE, Daegu, South Korea)
supplemented with 10% heat-inactivated fetal bovine
serum (FBS), 2 mM glutamine, 100 U/ml penicillin and
0.1 mg/ml streptomycin (Invitrogen, Carlsbad, CA) in a
humidified atmosphere of 95% air with 5% CO2 at 37°C.
Typically, the cells were seeded and maintained in cell cul-
ture plates (Costar, Corning Inc., Corning, NY) for 24 h
before stimulation with IL-1β and/or DEP. Negative con-
trols were grown without the addition of IL-1β.
All cell culture exposures were performed in three separate
experiments where each experiment was performed in
triplicate.
Preparation of DEP suspensions
The DEP suspension was prepared just prior to use. To
induce particle disaggregation, stock solutions of particles
were dispersed in PBS containing 0.05% Tween 80 (Sigma
Chemical, St. Louis, MO) at a concentration of 10 mg/ml
and then sonicated at output 5 and duty 30 of ultrasonic
disrupter for 2 min under cooling conditions [41]. Differ-
ent concentrations of particles were then diluted with
RPMI-1640. Culture medium containing percentage of
Tween 80 in the maximum concentration of DEP suspen-
sion was used as negative control in separate experiments.
Plasmid construction
A 2.3-kbp fragment of human hBD-2 promoter (-2274 to
+50) was amplified from genomic DNA by PCR using spe-
cific primers: forward 5'-GGC TCG AGG CTC AGA CAT
CAG CAC CCA AA-3' (Xho I) and reverse 5'-AAA AGC TTC
GAG AAG AGG AGA TAC AAG A-3' (Hind III). Both prim-
ers were designed based on GenBank Accession No,
AF071216, and additional restriction sites are indicated
by underlines. The synthesized fragments with the Xho I
and Hind III sites were subcloned into the promoter-less
firefly luciferase vector, pGL3-Basic (Promega, Madison,
WI) to generate hBD-2/Luc plasmid.
Transfection and luciferase assay
A549 cells (8 × 104 cells/well) were seeded into 12-well
culture plates 1 day before transfection. Cells were trans-
fected with 1.5 μg of firefly luciferase expression construct
and 200 ng of Renilla luciferase expression vector pRL-TK
(Promega) using transfectam reagent (Promega) accord-
ing to the manufacturer's protocol. Following transfec-
tion, cells were cultured for 20 h, and then exposed to
stimuli such as IL-1β and DEP.
After stimulation, cells were washed, harvested and lysed
in 50 μl of passive lysis buffer. Firefly and Renilla luciferase
activities were measured using a Dual-Luciferase reporter
assay kit (Promega) and MicroLumatPlus  LB96V lumi-
nometer (Berthold, Tokyo, Japan). Promoter activities are
expressed as relative light units, normalized to Renilla luci-
ferase activity.Particle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
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RT-PCR and real-time PCR analysis
Confluent A549 cells (8 × 105 cells/35-mm plate) were
incubated with IL-1β or IL-1β and DEP for 20 h. Total
RNA was then purified using an RNeasy mini kit (Qiagen,
Valencia, CA) and treated with RNase-free DNase set (Qia-
gen) to remove contaminated DNA. RT-PCR was per-
formed with 1.0 μg RNA using an AccuPower® RT-PCR kit
(Bioneer, Rockville, MD) according to the manufacturer's
protocol in a thermal cycler (MJ Research, INC., Water-
town, MA). The RT-PCR involved 38, 28 and 25 cycles for
hBD-2, IL-8 and β-tubulin, respectively, of the following
series: 30°C for 10 min, 42°C for 60 min, and 94°C for 5
min for RT; and 98°C for 10 s, 60°C for 10 s and 74°C for
30 s for PCR. To discriminate mRNA-derived PCR prod-
ucts from genomic DNA-derived products, the following
intron-spanning PCR primers were used: hBD-2, forward
5'-CCA GCC ATC AGC CAT GAG GGT-3' and reverse 5'-
GGA GCC ATC AGC CAT GAG GGT-3' (255 bp); IL-8, for-
ward 5'-ATG ACT TCC AAG CTG GCG TG-3' and reverse
5'-TTA TGA ATT CTC AGC CCT CTT CAA AAA CTT CTC-
3' (300 bp); and β-tubulin, forward 5'-GTT GGT CTG GAA
TTC TGT GAG-3' and reverse 5'-AAG AAA TCC AAG CTG
GAG TTC-3' (300 bp). All PCR products were analyzed on
a 2% agarose gel.
To quantify the levels of hBD-2 and IL-8 mRNA expres-
sion, real-time PCR quantification was performed. In
brief, 1 μg/ml of total RNA was reversed-transcribed to
cDNA using an AccuPower® RT PreMix (Bioneer). PCR
reactions were performed in a total volume of 25 μl
including 12.5 μl of 2 × IQ™ SYBR® green supermix (Bio-
Rad, Hercules, CA), 1 μl of cDNA and 1 μl of each primer
(10 pm/μl). The amplification and detection were carried
out in a Bio-Rad iCycler iQ system (Bio-Rad). The relative
genomic copy number was calculated using the compara-
tive threshold (Ct) method [42]. Briefly, the threshold
cycle (CT) for each gene was determined using the thermo-
cycler software and the average of three independent Cts/
DNA was calculated. The copy number of the target gene
normalized to an endogenous reference and relative to a
calibrator is given by the formula 2-ΔΔCT. β-Tubulin was
used as an endogenous reference.
Western blotting
Cytosol/membrane protein fractions were obtained using
NE-PER nuclear and cytoplasmic extraction reagents
(PIERCE, Rockford, IL) according to the manufacturer's
instruction. The protein concentration of extracts was
determined with Bradford reagent (Bio-Rad) using bovine
serum albumin as a standard. Equal amounts of extracts
(40μg/lane) were resolved by 10% SDS-PAGE gel electro-
phoresis and transferred onto a nitrocellulose membrane.
The membrane was then blocked with 5% non-fat dried
milk in TTBS (Tris-buffered saline with 0.05% Tween 20)
for 1 h and washed, and further incubated overnight with
specific primary antibodies to p65 NF-κB, IκB-α and β-
tubulin. The blots were washed four times with TTBS and
incubated for 1 h with appropriate secondary antibodies
coupled to horseradish peroxidase and developed in the
ECL Western detection reagents (Amersham-Biosciences,
Little Chalfont, Bucks., UK).
Statistics
Data are expressed as means ± SD. For luciferase assay, dif-
ferences between control and IL-1β and/or DEP-treated
samples were compared by matched pair t-test. P-values <
0.05 were considered statistically significant.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
HYN had the initial idea of performing the studies,
designed and coordinated the experimental work together
with YL, who had edited the final version of the manu-
script. EKA had carried out the cytotoxicity studies on DEP
and supported the experiments. HJK and KYL are special-
ists of internal medicine and pathology respectively and
have participated in the design of the study and the inter-
pretation of the data. CBL supported collection of refer-
ence DEP emitted from automobiles engine and involved
in the interpretation of the data. VV took the part of eval-
uation and review as the expert of pulmonary pathology,
and commented on the final manuscript. All authors read,
reviewed and approved final manuscripts.
Acknowledgements
This study was supported by grant No. R01-2004-000-10732-0 from the 
Basic Research Program of the Korea Science and Engineering Foundation
References
1. Boland S, Baeza-Squiban A, Fournier T, Houcine O, Gendron MC,
Chevrier M, Jouvenot G, Coste A, Aubier M, Marano F: Diesel
exhaust particles are taken up by human airway epithelial
cells in vitro and alter cytokine production.  Am J Physiol 1999,
276:L604-613.
2. Takano H, Yanagisawa R, Ichinose T, Sadakane K, Yoshino S,
Yoshikawa T, Morita M: Diesel exhaust particles enhance lung
injury related to bacterial endotoxin through expression of
proinflammatory cytokines, chemokines, and intercellular
adhesion molecule-1.  Am J Respir Crit Care Med 2002,
165:1329-1335.
3. Diaz-Sanchez D, Proietti L, Polosa R: Diesel fumes and the rising
prevalence of atopy: an urban legend?  Curr Allergy Asthma Rep
2003, 3:146-152.
4. Polosa R, Salvi S, Di Maria GU: Allergic susceptibility associated
with diesel exhaust particle exposure: clear as mud.  Arch Envi-
ron Health 2002, 57:188-193.
5. Yin XJ, Schafer R, Ma JY, Antonini JM, Weissman DD, Siegel PD,
Barger MW, Roberts JR, Ma JK: Alteration of pulmonary immu-
nity to Listeria monocytogenes by diesel exhaust particles
(DEPs). I. Effects of DEPs on early pulmonary responses.
Environ Health Perspect 2002, 110:1105-1111.
6. Castranova V, Ma JY, Yang HM, Antonini JM, Butterworth L, Barger
MW, Roberts J, Ma JK: Effect of exposure to diesel exhaust par-
ticles on the susceptibility of the lung to infection.  Environ
Health Perspect 2001, 109(Suppl 4):609-612.Particle and Fibre Toxicology 2006, 3:9 http://www.particleandfibretoxicology.com/content/3/1/9
Page 9 of 9
(page number not for citation purposes)
7. Yin XJ, Dong CC, Ma JY, Antonini JM, Roberts JR, Stanley CF, Schafer
R, Ma JK: Suppression of cell-mediated immune responses to
listeria infection by repeated exposure to diesel exhaust par-
ticles in brown Norway rats.  Toxicol Sci 2004, 77:263-271.
8. Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME,
Ferris BG Jr, Speizer FE: An association between air pollution
and mortality in six U.S. cities.  N Engl J Med 1993,
329:1753-1759.
9. Pope CA 3rd, Bates DV, Raizenne ME: Health effects of particu-
late air pollution: time for reassessment?  Environ Health Per-
spect 1995, 103:472-480.
10. Jang AS, Choi IS, Takizawa H, Rhim T, Lee JH, Park SW, Park CS:
Additive effect of diesel exhaust particulates and ozone on
airway hyperresponsiveness and inflammation in a mouse
model of asthma.  J Korean Med Sci 2005, 20:759-763.
11. Finkelman FD, Yang M, Orekhova T, Clyne E, Bernstein J, Whitekus
M, Diaz-Sanchez D, Morris SC: Diesel exhaust particles suppress
in vivo IFN-gamma production by inhibiting cytokine effects
on NK and NKT cells.  J Immunol 2004, 172:3808-3813.
12. Nilsen AM, Hagemann R, Eikas H, Egeberg K, Norkov T, Sundan A:
Reduction of IL-12 p40 production in activated monocytes
after exposure to diesel exhaust particles.  Int Arch Allergy Immu-
nol 2003, 131:201-208.
13. Imrich A, Ning YY, Koziel H, Coull B, Kobzik L: Lipopolysaccharide
priming amplifies lung macrophage tumor necrosis factor
production in response to air particles.  Toxicol Appl Pharmacol
1999, 159:117-124.
14. Bals R, Hiemstra PS: Innate immunity in the lung: how epithelial
cells fight against respiratory pathogens.  Eur Respir J 2004,
23:327-333.
15. van Wetering S, Sterk PJ, Rabe KF, Hiemstra PS: Defensins: key
players or bystanders in infection, injury, and repair in the
lung?  J Allergy Clin Immunol 1999, 104:1131-1138.
16. Schutte BC, McCray PB Jr: [beta]-defensins in lung host defense.
Annu Rev Physiol 2002, 64:709-748.
17. Oppenheim JJ, Biragyn A, Kwak LW, Yang D: Roles of antimicro-
bial peptides such as defensins in innate and adaptive immu-
nity.  Ann Rheum Dis 2003, 62(Suppl 2):ii17-21.
18. Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu
T, Chino N, Ihi T, Kohno S, Nakazato M: Increased concentra-
tions of human beta-defensins in plasma and bronchoalveo-
lar lavage fluid of patients with diffuse panbronchiolitis.
Thorax 2003, 58:425-430.
19. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Green-
berg EP, Valore EV, Welsh MJ, Ganz T, Tack BF, McCray PB Jr: Pro-
duction of beta-defensins by human airway epithelia.  Proc
Natl Acad Sci U S A 1998, 95:14961-14966.
20. Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Ver-
hasselt B, Van Cauwenberge P, Bachert C: Nasal polyps in patients
with and without cystic fibrosis: a differentiation by innate
markers and inflammatory mediators.  Clin Exp Allergy 2005,
35:467-472.
21. Liu L, Roberts AA, Ganz T: By IL-1 signaling, monocyte-derived
cells dramatically enhance the epidermal antimicrobial
response to lipopolysaccharide.  J Immunol 2003, 170:575-580.
22. Tsutsumi-Ishii Y, Nagaoka I: Modulation of human beta-
defensin-2 transcription in pulmonary epithelial cells by
lipopolysaccharide-stimulated mononuclear phagocytes via
proinflammatory cytokine production.  J Immunol 2003,
170:4226-4236.
23. Sakamoto N, Mukae H, Fujii T, Ishii H, Yoshioka S, Kakugawa T, Sug-
iyama K, Mizuta Y, Kadota J, Nakazato M, Kohno S: Differential
effects of alpha- and beta-defensin on cytokine production by
cultured human bronchial epithelial cells.  Am J Physiol Lung Cell
Mol Physiol 2005, 288:L508-513.
24. Monick MM, Yarovinsky TO, Powers LS, Butler NS, Carter AB, Gud-
mundsson G, Hunninghake GW: Respiratory syncytial virus up-
regulates TLR4 and sensitizes airway epithelial cells to endo-
toxin.  J Biol Chem 2003, 278:53035-53044.
25. Hoshi H, Ohno I, Honma M, Tanno Y, Yamauchi K, Tamura G, Shirato
K: IL-5, IL-8 and GM-CSF immunostaining of sputum cells in
bronchial asthma and chronic bronchitis.  Clin Exp Allergy 1995,
25:720-728.
26. Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, Szell M,
Dobozy A, Kemeny L: Microbial compounds induce the expres-
sion of pro-inflammatory cytokines, chemokines and human
beta-defensin-2 in vaginal epithelial cells.  Microbes Infect 2005,
7:1117-1127.
27. Jang BC, Lim KJ, Paik JH, Kwon YK, Shin SW, Kim SC, Jung TY, Kwon
TK, Cho JW, Baek WK, Kim SP, Suh MH, Suh SI: Up-regulation of
human beta-defensin 2 by interleukin-1beta in A549 cells:
involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB.
Biochem Biophys Res Commun 2004, 320:1026-1033.
28. Aarbiou J, Rabe KF, Hiemstra PS: Role of defensins in inflamma-
tory lung disease.  Ann Med 2002, 34:96-101.
29. Steerenberg PA, Zonnenberg JA, Dormans JA, Joon PN, Wouters IM,
van Bree L, Scheepers PT, Van Loveren H: Diesel exhaust particles
induced release of interleukin 6 and 8 by (primed) human
bronchial epithelial cells (BEAS 2B) in vitro.  Exp Lung Res 1998,
24:85-100.
30. Ma JY, Ma JK: The dual effect of the particulate and organic
components of diesel exhaust particles on the alteration of
pulmonary immune/inflammatory responses and metabolic
enzymes.  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2002,
20:117-147.
31. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T: Airway epithelial
cells release MIP-3alpha/CCL20 in response to cytokines and
ambient particulate matter.  Am J Respir Cell Mol Biol 2003,
28:648-654.
32. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP 3rd,
Toews GB, Westwick J, Strieter RM: Interleukin-8 gene expres-
sion by a pulmonary epithelial cell line. A model for cytokine
networks in the lung.  J Clin Invest 1990, 86:1945-1953.
33. Krakauer T: Stimulant-dependent modulation of cytokines
and chemokines by airway epithelial cells: cross talk between
pulmonary epithelial and peripheral blood mononuclear
cells.  Clin Diagn Lab Immunol 2002, 9:126-131.
34. Ganz T: Antimicrobial polypeptides in host defense of the res-
piratory tract.  J Clin Invest 2002, 109:693-697.
35. Strieter RM, Belperio JA, Keane MP: Cytokines in innate host
defense in the lung.  J Clin Invest 2002, 109:699-705.
36. Becker MN, Diamond G, Verghese MW, Randell SH: CD14-
dependent lipopolysaccharide-induced beta-defensin-2
expression in human tracheobronchial epithelium.  J Biol Chem
2000, 275:29731-29736.
37. Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, Matsu-
kura S: Elevated levels of alpha-defensins in plasma and BAL
fluid of patients with active pulmonary tuberculosis.  Chest
2002, 121:519-526.
38. Hiratsuka T, Nakazato M, Date Y, Ashitani J, Minematsu T, Chino N,
Matsukura S: Identification of human beta-defensin-2 in respi-
ratory tract and plasma and its increase in bacterial pneu-
monia.  Biochem Biophys Res Commun 1998, 249:943-947.
39. van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiem-
stra PS: Neutrophil defensins stimulate the release of
cytokines by airway epithelial cells: modulation by dexame-
thasone.  Inflamm Res 2002, 51:8-15.
40. Van Wetering S, Mannesse-Lazeroms SP, Van Sterkenburg MA, Daha
MR, Dijkman JH, Hiemstra PS: Effect of defensins on interleukin-
8 synthesis in airway epithelial cells.  Am J Physiol 1997,
272:L888-896.
41. Amakawa K, Terashima T, Matsuzaki T, Matsumaru A, Sagai M,
Yamaguchi K: Suppressive effects of diesel exhaust particles on
cytokine release from human and murine alveolar macro-
phages.  Exp Lung Res 2003, 29:149-164.
42. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative
PCR.  Genome Res 1996, 6:986-994.